Astal Laboratories Limited (BOM:512600)

Astal Laboratories Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Interest and Dividend Income	-	-	-	-	2.11	2.03
Total Interest Expense	11.56	7.01	0.11	-	-	-
Net Interest Income	-11.56	-7.01	-0.11	-	2.11	2.03
Other Revenue	1,009	643.56	236.61	36.07	-	-
Revenue Before Loan Losses	997.92	636.55	236.5	36.07	2.11	2.03
Revenue	997.92	636.55	236.5	36.07	2.11	2.03
Revenue Growth (YoY)	113.00%	169.15%	555.71%	1611.01%	3.80%	0.59%
Salaries & Employee Benefits	13.63	13.39	4.66	-	0.85	0.62
Cost of Services Provided	832.8	484.21	215.42	35.67	0.11	0.13
Other Operating Expenses	15.92	16.96	5.27	-	1.12	1.05
Total Operating Expenses	866.62	516.78	225.64	35.75	2.23	1.95
Operating Income	131.29	119.78	10.87	0.32	-0.12	0.08
EBT Excluding Unusual Items	131.29	119.78	10.87	0.32	-0.12	0.08
Pretax Income	131.29	119.78	10.87	0.32	-0.17	0.08
Income Tax Expense	32.24	30.52	3.02	0.16	0	0.02
Net Income	99.06	89.25	7.85	0.16	-0.17	0.06
Net Income to Common	99.06	89.25	7.85	0.16	-0.17	0.06
Net Income Growth	123.27%	1037.42%	4684.76%	-	-	-
Shares Outstanding (Basic)	10	10	5	4	4	4
Shares Outstanding (Diluted)	13	11	5	4	4	4
Shares Change (YoY)	71.11%	119.71%	27.10%	-	-	-
EPS (Basic)	9.62	9.08	1.55	0.04	-0.04	0.02
EPS (Diluted)	7.78	8.04	1.55	0.04	-0.04	0.02
EPS Growth	30.48%	417.71%	3689.19%	-	-	-
Free Cash Flow	-154.51	-182.92	-114.96	-14.37	-2.49	-1.86
Free Cash Flow Per Share	-12.14	-16.48	-22.76	-3.62	-0.63	-0.47
Operating Margin	13.16%	18.82%	4.59%	0.89%	-5.74%	3.99%
Profit Margin	9.93%	14.02%	3.32%	0.46%	-8.11%	2.96%
Free Cash Flow Margin	-15.48%	-28.74%	-48.61%	-39.83%	-118.03%	-91.73%
Effective Tax Rate	24.55%	25.48%	27.78%	48.75%	-	25.77%
Revenue as Reported	1,009	643.56	236.61	-	2.11	2.03

Source: S&P Global Market Intelligence. Financial Services template. Financial Sources.